Citius Oncology Inc. (CTOR) saw an uptrend of 13.75% in the recent trading with $1.82 being its most recent. The current price level -96.29% lower than the highest price of $49.00 marked by the stock while trading over the past 52-weeks, whereas it is 20.53% higher than the lowest price of $1.51 the company dropped to over past 52-weeks. The latest news story on CTOR appeared in (PR Newswire) under the title “Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
Sponsored
Squeezing the time span to 30 day period shows us the stock is currently trading -13.33% below one month high and is +20.53% above of the lowest during that time. Looking into the simple moving average, Citius Oncology Inc. (CTOR)’s stock stands at a SMA-50 of $7.4806 while that of 5-day is reading $1.6540.
Daily rise and fall of price influence many of the traders, and in order to overcome the fluctuating effect of that and to watch the stock closely, traders focus more on stock’s 200-day moving average. At various points in trading activity, investors are more likely to be making use of that measure as a strong indicator in figuring out their support and resistance levels, and CTOR’s SMA-200 as of now is $10.0494.
Citius Oncology Inc. Earnings – What Happened With CTOR
Coming around sales and income figures on CTOR Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
CTOR – Citius Oncology Inc. Stock Earnings Estimates
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 2.34 million. CTOR does have institutional investors; and they hold 25.44% of the stock.
Citius Oncology Inc. – Insider Activity and Holdings
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Citius Oncology Inc. has a debt to equity ratio of 0.04.
Technical Analysis of Citius Oncology Inc. (NASDAQ:CTOR) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Citius Oncology Inc. (CTOR), we notice that the stock’s 20-day average volume is at 205,695 shares and 50% of short term indicators are suggesting the stock as Sell. Medium term indicators at an average of 100% are spotting the stock at Sell with its 50-day average volume of 267,550 shares. And to end, CTOR’s 100-day average volume is 140,586 shares with 100% of the long-term indicators pointing towards Sell for the stock.
